• Help people with EB

    Your support of DEBRA International or a national EB group enables us to provide the best quality of life for families and individuals affected by EB.

Donation Account: IBAN AT65 6000 0005 1004 5254, BIC BAWAATWW, DEBRA International, Am Heumarkt 27/1, 1030 Vienna

donate now

Research News


Amryt Pharma EASE Phase III Clinical Trial to study the efficacy and safety of Oleogel-S10 in Epidermolysis Bullosa

Oleogel-S10 is a topical gel that has demonstrated accelerated wound healing in adult patients with partial thickness wounds. Partial thickness wounds are areas of skin where the upper layers have been lost, for example by a burn or during surgical skin grafting. Oleogel-S10 has been authorised for this particular use by the European Union (EU) under the brand name Episalvan®. The active...[more]


EB researchers break new ground with skin graft trial - what does this all mean and what happens next?

We've thought of some of the answers to questions you may have regarding this exciting research[more]


EB researchers break new ground with skin graft trial

An international team of researchers has broken new ground with a pioneering skin grafting procedure, reconstructing a fully functional outer skin – or epidermis – for a child suffering from a severe, and often fatal, form of Epidermolysis Bullosa (EB) – a genetic skin condition that causes constant pain due to unstoppable internal and external blistering. Researcher Michele De Luca and...[more]


Castle Creek Enrolling EB Simplex Patients in DELIVERS Study of Diacerein 1% Ointment (CCP-020)

Potentially disease-modifying therapy may block inflammatory signaling pathway, which could strengthen epidermal tissue and support healing.[more]


5th and 6th of December: DEBRA Austria and DEBRA UK - Wound Healing in EB roundtable meeting in London

Full Report on Wound Healing in EB Clinical Research Review and Priority-setting Consensus Meeting[more]